TSP Capital Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$784K Hold
27,500
– – 0.2% 40
2026
Q2
$662K Buy
+27,500
New +$719K 0.16% 41
2026
Q1
– Hold
0
– – – 40
2025
Q4
– Sell
-44,100
Closed -$1.11M – 40
2025
Q3
$1.12M Buy
+44,100
New +$1.09M 0.3% 37
2025
Q2
– Sell
-44,100
Closed -$1.03M – 35
2025
Q1
$1.12M Sell
44,100
-600
-1% -$15.7K 0.37% 37
2024
Q4
$1.19M Hold
44,700
– – 0.4% 37
2024
Q3
$1.29M Hold
44,700
– – 0.4% 37
2024
Q2
$1.25M Hold
44,700
– – 0.39% 37
2024
Q1
$1.24M Hold
44,700
– – 0.4% 38
2023
Q4
$1.29M Sell
44,700
-40
-0.1% -$1.21K 0.45% 36
2023
Q3
$1.48M Sell
44,740
-3,000
-6% -$106K 0.57% 32
2023
Q2
$1.75M Sell
47,740
-1,640
-3% -$63.8K 0.63% 33
2023
Q1
$2.01M Sell
49,380
-1,700
-3% -$73.4K 0.73% 33
2022
Q4
$2.62M Buy
+51,080
New +$2.45M 0.98% 28
2022
Q3
– Hold
0
– – – 29
2022
Q2
– Hold
0
– – – 28
2022
Q1
– Hold
0
– – – 26
2021
Q4
– Hold
0
– – – 26
2021
Q3
– Hold
0
– – – 30
2021
Q2
– Sell
-51,080
Closed -$1.99M – 33
2021
Q1
$1.85M Sell
51,080
-960
-2% -$34.1K 0.65% 33
2020
Q4
$1.92M Buy
+52,040
New +$1.91M 0.68% 28
2020
Q3
– Hold
0
– – – 28
2020
Q2
– Hold
0
– – – 31
2020
Q1
– Hold
0
– – – 28
2019
Q4
– Hold
0
– – – 28
2019
Q3
– Hold
0
– – – 26
2019
Q2
– Hold
0
– – – 25
2019
Q1
– Sell
-57,313
Closed -$2.3M – 26
2018
Q4
$2.37M Buy
+57,313
New +$2.38M 1.33% 28
2018
Q3
– Sell
-59,843
Closed -$2.3M – 27
2018
Q2
$2.06M Sell
59,843
-1,054
-2% -$36K 1.06% 29
2018
Q1
$2.05M Sell
60,897
-2,055
-3% -$70.6K 0.98% 31
2017
Q4
$2.16M Sell
62,952
-527
-0.8% -$18K 0.98% 29
2017
Q3
$2.15M Buy
+63,479
New +$2.04M 1.03% 30
2017
Q2
– Hold
0
– – – 31
2017
Q1
– Hold
0
– – – 31
2016
Q4
– Hold
0
– – – 33
2016
Q3
– Sell
-65,324
Closed -$2.18M – 29
2016
Q2
$2.18M Sell
65,324
-685
-1% -$21.9K 1.13% 28
2016
Q1
$1.86M Sell
66,009
-2,797
-4% -$79.9K 1.02% 30
2015
Q4
$2.11M Sell
68,806
-685
-1% -$21.5K 1.13% 28
2015
Q3
$2.07M Sell
69,491
-6,851
-9% -$220K 1.16% 26
2015
Q2
$2.43M Buy
+76,342
New +$2.49M 1.13% 29
2015
Q1
– Hold
0
– – – 27
2014
Q4
– Hold
0
– – – 29
2014
Q3
– Sell
-86,461
Closed -$2.43M – 30
2014
Q2
$2.44M Buy
+86,461
New +$2.46M 1.06% 29
2014
Q1
– Hold
0
– – – 26
2013
Q4
– Hold
0
– – – 29
2013
Q3
– Hold
0
– – – 30
2013
Q2
– Hold
0
– – – 28

Other funds holding PFE

TSP Capital Management Group's PFE Position: Q3 2026 in Review

TSP Capital Management Group held its Pfizer (PFE) position steady in Q3 2026 at 27,500 shares worth $784K. The position accounts for 0.2% of the portfolio, ranked #40.

TSP Capital Management Group first reported a position in PFE in Q2 2014 and has held it in 26 quarters since. The position peaked at $2.62M in Q4 2022. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • TSP Capital Management Group held 27,500 shares of Pfizer worth $784K as of Q3 2026.
  • TSP Capital Management Group left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.2% of TSP Capital Management Group's portfolio in Q3 2026, its #40 holding.
  • TSP Capital Management Group first reported a position in Pfizer in Q2 2014 and has held it in 26 quarters since.
  • TSP Capital Management Group's Pfizer position peaked at $2.62M in Q4 2022.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on TSP Capital Management Group's 13F filing for Q3 2026, filed 15 Oct 2026.